← All candidates
Two insider buys in the last year — $5.00M in all.
13 filings on record.
ACETAdicet Bio, Inc.
NasdaqCM · Healthcare · $89.78M
$9.73
-12.32% · Sep 15
Two insider buys in the last year — $5.00M in all.
Nothing in the last fortnight.
Price · 1Y · daily● 2 buys◆ 4 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
Reverse-split 2×. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what ACET ever actually traded at. The drop is real, but those huge old numbers aren't.
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$89.78M
Float
7.4M
79% public
Short % float
Pro
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
10% owner
Orbimed Advisors LLC
Bought $3.50M on Oct 8 — 3,500,000 sh @ $1.00, held indirect, 78% of their stake.
1 of 2 positions beat the S&P
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
6 more transactions on Pro →Context
Wall St
$34.83 avg target
+258.0% vs today · 6 analysts · consensus Strong Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
3 of 4 quarters beat
Q1 '26−$1.88 act+$1.20
Q4 '25−$2.94 act+$0.05
Q3 '25−$4.64 act+$0.43
Q2 '25−$5.44 act−$0.69
Coverage
Is Adicet Bio (ACET) Stock Outpacing Its Medical Peers This Year?Zacks · 07-01Adicet Bio Teases Autoimmune Data Catalysts, PSMA Plans at Jefferies ConferenceMarketBeat · 06-04Are Medical Stocks Lagging Adicet Bio (ACET) This Year?Zacks · 05-28Wall Street Analysts Believe Adicet Bio (ACET) Could Rally 319.64%: Here's is How to TradeZacks · 05-25
The file stays open
13 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice